Connect with us

Health

Women’s heart disease risk could be predicted up to 30 years in advance with one blood test, study finds

Published

on

Women’s heart disease risk could be predicted up to 30 years in advance with one blood test, study finds

Predicting a woman’s future heart disease risk could be as simple as administering a single blood test to screen for three risk factors.

That’s according to research published in The New England Journal of Medicine on Saturday — research that was also presented at the European Society of Cardiology (ESC) Congress this weekend.

The study, which included nearly 30,000 women averaging 55 years of age, measured two types of fat in the bloodstream along with a certain type of protein with a blood test in 1993, then monitored the participants’ health for a 30-year period, the researchers said.

WHEN MEASURING HEART ATTACK RISK, ONE IMPORTANT RED FLAG IS OFTEN OVERLOOKED, DOCTORS SAY

“The strongest predictor of risk was a simple blood measure of inflammation known as high sensitivity C-reactive protein, or hsCRP, followed by cholesterol and lipoprotein(a),” lead study author Dr. Paul Ridker, director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital in Boston, told Fox News Digital.

Advertisement

The study, which included nearly 30,000 women averaging 55 years of age, measured two types of fat in the bloodstream along with a certain type of protein. (iStock)

“Knowing all three predicted risks not just at five or 10 years, but at 20 and 30 years, gives us a road map for how to target specific therapies for the individual patient, rather than an overly simple ‘one-size-fits-all’ approach,” he said.

C-reactive protein (CRP) is a protein made by the liver that rises when inflammation occurs in the body, according to Mayo Clinic. 

High levels of the protein indicate an elevated risk of heart disease.

COLORADO CARDIAC NURSE, AFTER THREE HEART ATTACKS, OFFERS SURVIVAL TIPS: ‘LISTEN TO YOUR GUT’

Advertisement

LDL cholesterol — also known as the “bad” cholesterol — can build up in the arteries and raise the chances of heart attack or stroke, Mayo Clinic noted.

Lipoprotein(a), or Lp(a), is a type of LDL cholesterol that can also cause plaque buildup in the arteries.

“This is a large, convincing study that puts together three predictive blood tests that haven’t been looked at in this way before.”

Women with the highest levels of LDL cholesterol were found to have a 36% increased associated risk for heart disease compared to those with the lowest levels, the researchers found. 

Those with the highest levels of Lp(a) had a 33% greater risk.

Advertisement

The highest levels of CRP put women at a 70% increased associated risk.

LDL cholesterol, also known as the “bad” cholesterol, can build up in the arteries and raise the chances of heart attack or stroke. (iStock)

Women who had high levels of all three measures were 1½ times more likely to experience a stroke and more than three times as likely to have coronary heart disease, the researchers found.

While most doctors measure cholesterol, very few measure hsCRP and Lp(a), Ridker noted. 

THE 9 MOST COMMON QUESTIONS WOMEN OVER 40 ASK THEIR DOCTORS, ACCORDING TO A MENOPAUSE EXPERT

Advertisement

“It is a truism of medicine that doctors will not treat what they do not measure.”

The fact that a single combination blood test predicted risk 30 years later is “astonishing,” the researcher said.

“It is a truism of medicine that doctors will not treat what they do not measure.”

“It tells us how much silent risk we simply are unaware of, and gives us an opportunity to start preventive efforts far earlier in life,” he added.

Dr. Marc Siegel, senior medical analyst for Fox News and clinical professor of medicine at NYU Langone Medical Center, was not involved in the study, but said it is a “big step forward” in using a combination of blood tests to determine a woman’s cardiac risk.

Advertisement

“This is a large, convincing study that puts together three predictive blood tests that haven’t been looked at in this way before,” Siegel told Fox News Digital.

Women who had high levels of all three measures were 1½ times more likely to experience a stroke and more than three times more likely to have coronary heart disease. (iStock)

“Since inflammation can cause heart attacks, it is confirmatory that an elevated inflammation marker (CRP) conveys a 70% increased risk for heart disease,” he went on.

“LDL and Lp(a) have both previously shown an increased risk of heart disease.”

Siegel predicts that in the future, blood markers like these will be used in combination with artificial intelligence to determine the risk of heart disease and stroke.

Advertisement

      

Based on these findings, Ridker recommends that patients ask their physicians to specifically measure hsCRP and Lp(a).

“The time has come for our guidelines to change.”

Some patients will benefit from drug therapies to reduce inflammation and lower cholesterol levels, the researcher said. (iStock)

In Ridker’s experience, women tend to be less concerned about heart disease than men.

Advertisement

“Unfortunately, our traditional screening guidelines rarely identify at-risk women until they are in their late 60s or 70s,” he said. 

“Yet prevention must start in our 30s and 40s for it to be most effective.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

While prevention efforts should initially focus on a heart-healthy diet, regular exercise, smoking cessation and stress management, some patients will benefit from drug therapies to reduce inflammation and lower cholesterol levels, according to Ridker.

Based on these findings, the researchers recommend that patients ask their physicians to specifically measure hsCRP and Lp(a). (iStock)

Advertisement

The main limitation of the study is that the women who participated were health professionals, the researchers acknowledged.

“Yet in other settings, we know this is also true for men — and, if anything, an even greater concern for minority individuals,” Ridker said.

For more Health articles, visit www.foxnews.com/health

The research was funded by the National Institutes of Health (NIH), the National Heart, Lung, and Blood Institute (NHLBI), and the National Cancer Institute (NCI).

Advertisement

Health

GLP-1 Drugs Linked to Osteoporosis and Gout: Here’s How To Stay Safe

Published

on

GLP-1 Drugs Linked to Osteoporosis and Gout: Here’s How To Stay Safe


Advertisement




GLP-1 Drugs Linked To Increased Risk of Osteoporosis and Gout | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Ozempic-style drugs could slash complication risks after heart attacks, research suggests

Published

on

Ozempic-style drugs could slash complication risks after heart attacks, research suggests

NEWYou can now listen to Fox News articles!

A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked after a heart attack, according to a study published this week in Nature Communications.

The research, led by the University of Bristol and University College London, identified a biological brain-gut-heart signaling pathway. 

This discovery appears to explain how GLP-1 drugs — which mimic glucagon-like peptide-1, a hormone that helps regulate blood sugar and appetite — protect heart tissue from a condition known as “no-reflow.”

“In nearly half of all heart attack patients, tiny blood vessels within the heart muscle remain narrowed, even after the main artery is cleared during emergency medical treatment,” Dr. Svetlana Mastitskaya, the study’s lead author and a senior lecturer at Bristol Medical School, said in a press release.

Advertisement

“This results in a complication known as ‘no-reflow,’ where blood is unable to reach certain parts of the heart tissue.”

In nearly half of all heart attack patients, tiny capillaries (blood vessels) remain narrowed even after the main blocked artery is cleared. (iStock)

This lack of blood flow increases the risk of heart failure and death within a year. GLP-1 medications could prevent this, according to the researchers.

How it works

When the GLP-1 hormone is released in the gut or administered as a drug, it sends a signal to the brain, which then sends a signal to the heart that switches on special potassium channels in tiny cells called pericytes.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

When these channels open, the pericytes relax, which allows the small blood vessels (capillaries) to widen and improve blood flow to the heart muscle, the researchers noted.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The new study used animal models and cellular imaging to track how GLP-1 interacts with heart tissue. When the researchers removed the potassium channels, the drugs no longer protected the heart — confirming they play a key role.

The findings suggest that existing GLP-1 medications, already used for type 2 diabetes and obesity, could be repurposed as emergency treatments. (iStock)

The findings suggest that existing GLP-1 medications, already used for type 2 diabetes and obesity, could be repurposed as emergency treatments during or immediately after a heart attack to reduce tissue damage.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The researchers noted several limitations, including that the study relied on animal models.

Clinical trials are necessary to determine whether the brain-gut-heart pathway operates with the same timing and efficacy in humans.

While the study highlights the drug’s immediate benefits during a heart attack, it des not establish whether long-term use of these drugs provides a pre-existing level of protection. (iStock)

Additionally, while the study highlights the drug’s immediate benefits during a heart attack, it does not establish whether long-term use of the medication provides a pre-existing level of protection.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The research was primarily funded by the British Heart Foundation.

Related Article

Eating oatmeal for two days has unexpected impact on heart health, study suggests
Advertisement
Continue Reading

Health

Do collagen supplements really improve skin? Major review reveals the truth

Published

on

Do collagen supplements really improve skin? Major review reveals the truth

NEWYou can now listen to Fox News articles!

Collagen supplements have exploded in popularity, touted as everything from an anti-aging miracle to a muscle recovery booster.

But a sweeping new review conducted by U.K. researchers suggests that while collagen may help improve skin elasticity and ease arthritis pain, it does little for athletic performance or wrinkle reduction.

Researchers from Anglia Ruskin University analyzed 16 systematic reviews and 113 randomized controlled trials involving nearly 8,000 participants worldwide, which they say is the most extensive evaluation of collagen’s health effects to date. 

The review found consistent evidence that collagen supplementation improves skin elasticity and hydration over time and provides significant relief from osteoarthritis-related joint pain and stiffness, according to findings published in Aesthetic Surgery Journal Open Forum. 

Advertisement

A large U.K. review found that collagen supplements may improve skin elasticity and hydration over time. (iStock)

The researchers, however, did not find meaningful improvements in post-exercise muscle recovery, soreness or tendon mechanical properties (strength, springiness and stretch resistance).

“Collagen is not a cure-all, but it does have credible benefits when used consistently over time, particularly for skin and osteoarthritis,” co-author Lee Smith, professor of public health at Anglia Ruskin University, said in a statement.

EXPERIMENTAL SERUM SHOWS PROMISE IN REVERSING BALDNESS WITHIN 20 DAYS

“Our findings show clear benefits in key areas of healthy aging, while also dispelling some of the myths surrounding its use,” Smith added.

Advertisement

Collagen, the most abundant protein in the body, supports skin, bones, tendons, cartilage and connective tissue, according to experts. Natural collagen production begins to drop in early adulthood and declines more sharply with age.

The study found that collagen supplements may help reduce joint pain and stiffness in people with osteoarthritis. (iStock)

The review found that long-term collagen supplementation was linked to improved skin firmness and hydration, but did not help skin roughness — a proxy for visible wrinkles. 

Benefits appear to accumulate gradually, suggesting that collagen should not be viewed as an “anti-wrinkle ‘quick fix,’ but as a foundational dermal support for individuals seeking holistic skin maintenance,” the researchers said.

Advertisement

“If we define anti-aging as a product or technique designed to prevent the appearance of getting older, then I believe our findings do support this claim for some parameters,” Smith told the BBC. “For example, an improvement in skin tone and moisture is associated with a more youthful-looking appearance.”

Collagen supplementation was linked to reduced pain and stiffness in people with osteoarthritis, with stronger benefits seen over longer periods of use, and showed modest improvements in muscle mass and tendon structure that may support healthy aging. 

Collagen did not significantly improve skin roughness, a marker of visible wrinkles. (iStock)

However, it did not show meaningful results when used as a fast-acting sports performance supplement, and evidence for benefits related to cholesterol, blood sugar, blood pressure and oral health was mixed or inconclusive.

Dr. Daniel Ghiyam, a California-based physician and longevity specialist, said the findings align with what he sees in clinical practice.

Advertisement

CLICK HERE FOR MORE LIFESTYLE STORIES

“Collagen is a targeted support tool, not a foundation of health or performance,” Ghiyam, who was not involved in the study, told Fox News Digital. “When marketed that way, it makes sense. When marketed as a cure-all, it doesn’t hold up to the data.”

The authors noted that while many previous collagen studies have received financial support from the supplement industry, the current review did not receive industry funding.

Experts say collagen supplements may offer modest benefits for skin hydration and joint comfort, but they are not a cure-all. (iStock)

The team called for more high-quality clinical trials examining long-term outcomes, optimal dosages and differences between collagen sources, such as marine, bovine and plant-based alternatives. 

Advertisement

Among its limitations, the review could not determine whether certain forms of collagen work better than others or what the optimal regimen should be. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

While the review included randomized controlled trials, the quality of the studies varied, with newer research generally showing stronger results.

Experts say more data and studies are needed to build on the findings. They also noted that diet plays a crucial role in skin health.

Collagen supplements, often sold as powders or pills, may improve skin elasticity and ease joint pain, experts say. (iStock)

Advertisement

Dr. Erum Ilyas, a Pennsylvania-based dermatologist and chair of dermatology at Drexel University College of Medicine, noted that the review analyzed previously published meta-analyses rather than generating new primary data.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“At this time, I have not seen sufficiently strong independent evidence to routinely recommend collagen supplements to my patients,” Ilyas, who was not involved in the review, told Fox News Digital.

“Although some studies show modest improvements in markers such as hydration and elasticity, there remains limited independent, biopsy-confirmed evidence demonstrating sustained increases in dermal collagen content,” she added.

Fox News Digital has reached out to the researchers for comment.

Advertisement

Related Article

Cosmetic fillers can cause deadly complication, experts warn — but new tech exposes it
Continue Reading

Trending